We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
By the Side of our Communities – West Wins the Pharma Industry Award for Corporate Social Responsibility Program of the Year
Nurturing a culture of philanthropy and community involvement is one of the defining characteristics of West. Team members around the world take their responsibility to give back very seriously, donating considerable time and resources to help create a healthier world. West without Borders, our team member-led giving programme, has raised millions of dollars since its inception in 2004 and the initiatives in Ireland were recently recognised at the Pharma Industry Awards for Corporate Social Responsibility Programme of the Year.
West without Borders- Ireland Initiatives
West has two manufacturing sites in Ireland, based in Dublin and Waterford. Despite the backdrop of the global pandemic, the last two years were very successful for the West without Borders teams raising a combined total of over €105,000 for Temple Street Children’s Hospital and BUMBLEance, the Children’s National Ambulance Service.
Temple Street Hospital and BUMBLEance are both charities that resonate with our team members as many have encountered the amazing work they do over the course of their children’s lives. BUMBLEance, the official Children’s National Ambulance Service of Ireland, provides safe and comfortable transportation for Ireland’s youngest patients as they travel between their homes and hospitals, hospices, treatment centres, and respite centres nationwide.
West Active August
West Active August
Each West site has a dedicated charity committee, including a cross section of team members from the various functions and they are responsible for the West without Borders strategy - organising all the fundraising related activities and being the key interface with the charities. A calendar of events for the year ahead is set out in the first quarter of each year and these events include things like sponsored runs, cake sales, raffles, and virtual marathons. In 2020, the Dublin team came up with a new idea to overcome the challenge of social distancing by introducing the “West Active August” campaign, where individual team members get active during August to raise much needed funds. The target was 10,000 km in 10 days and each year the target was smashed, despite the many personal challenges being faced because of the pandemic.
Tom Clarke, Site Director, Dublin said, “Empowering our team members to support local communities helps foster a sense of meaning and pride in their roles at the company and gives them a chance to develop people skills, adaptability, and empathy, as part of being good citizens in their community. I applaud the tremendous work done to date by our teams in Dublin and Waterford”.
Over the past nine years West Dublin has raised an amazing €376,000 for the renal unit at Temple St. Hospital and has funded dialysis machines, patient monitors, dialysis chairs, a multipurpose room in the recently opened Renal and Neurology Outpatient unit and more recently funded a Cubbie Booth for the Autism & Intellectual Disability Working Group. Commenting on the continued partnership, Denise Fitzgerald CEO of Children’s Health Foundation Temple Street said: “Over the past nine years we have developed a brilliant partnership with the employees at West’s Dublin facility. The tremendous work of the staff there to raise vital funds has helped us source cutting-edge equipment and diagnostics which saves children’s lives every day. We are so grateful for the enthusiasm, hard work and sheer drive of the West team. It helps us ensure that the children of Ireland get the world-class care they need and deserve, and we look forward to this partnership continuing into the future.”
More about BUMBLEance
Donations raised for BUMBLEance went towards sponsoring a vehicle that will service children within the South-East Region of Ireland, making trips to hospital for vital treatments more comfortable for our youngest patients, the vehicle was officially launched in July 2021. BUMBLEance had planned to set up a depot in Waterford that aimed to provide a dedicated service for children in the Southeast Region but unfortunately due to COVID-19 this was not feasible. However, as an alternative West’s site in Waterford partnered with BUMBLEance by providing a permanent dedicated parking space on site equipped with electricity to ensure BUMBLEance can help children in the Southeast Region. In addition, as part of West Waterford’s ‘West without Borders’ campaign, West and its team members have donated funds of over €50,000 to date to support BUMBLEance.
Some of the Waterford team pictured with the BUMBLEance parked at the West site
Photographed accepting the Pharma Industry Award for Corporate Social Responsibility Programme of the Year (L-R) Tom Clarke Senior Site Director West, Maureen Gilbert General Manager Source Bio Science Ireland, Mary Mulcahy Quality Manager West, Martina Doyle Director Business Development West, and Emma Kilgallon Senior Manager HR West
Corporate Social Responsibility at West
Corporate Social Responsibility is highly motivating for team members at West. Our CSR activities help improve team member morale and support the process of recruitment and retention due to the positive culture and environment that is generated as a result. Empowering our team members to lead CSR initiatives provides a sense of meaning and pride outside of their day-to-day roles within West. By working and volunteering together on fun initiatives our team members learn to work better together on important projects. The CSR opportunities give everyone a chance to develop new skills such as people skills, adaptability, and empathy, becoming more open minded and self-aware, as well as building partnerships, teamwork and questioning each other. These are all ingredients that contribute to the positive giving culture at West.
To learn more about Corporate Responsibility at West, please click here.
The concept of Extractables and Leachables (E&L) is well known today, especially since the publication of United States Pharmacopeia (USP) monographs <1663><sup>1</sup> and <1664><sup>2</sup>. USP <1663> defined extractables as “organic and inorganic chemical entities that are released from a pharmaceutical packaging/delivery system and into an extraction solvent under laboratory conditions.” Leachables are defined in USP <1664> as “foreign organic and inorganic chemical entities that are present in a packaged drug product because they have migrated into the packaged drug product from a packaging/delivery system, packaging component or packaging material of construction under normal conditions of storage and use or during drug product stability studies.”
For many years, West has offered several ready-to-sterilize products that are qualified for a minimum 3-log Bacterial Endotoxin Reduction (BER). “Ready-to-sterilize” is known to West customers in Europe as “RS” quality. In other regions, such as South America or Asia, the ready-to-sterilize line of products includes our Superior Clean Product® (SCP) components and Enhanced Performance Products (EPP). These offerings reflect West’s commitment to quality components that support pharmaceuticals and biopharmaceuticals throughout the product lifecycle, while also fulfilling various regional market needs.
Glucose monitoring, or measuring the amount of sugar in the blood, is a vital part of everyday care for those suffering from diabetes. Traditional tests require patients to prick their fingers and place a drop of blood on a test strip. The strip is then placed in a glucose meter that reports the results to the patient. While this test is very accurate, it offers a reading for only a single point in time. For patients to get a range of their blood glucose levels, more frequent data is needed at a variety of different times.
This is part two of a three-part series about how recent updates to ICH Q2(R2) and Q14 can be applied to the development and validation of leachables methods. You can find part one <a href="/zh-cn/blog/2024/october/drug-packaging-extractables-leachables-guidelines">here</a>.
“There is no disease so rare that it does not deserve attention.” This statement from Orphanet, a portal for rare diseases and orphan drugs, makes that point very clearly. For patients suffering from a rare disease, orphan drugs and the special attention that they receive during the drug review and approval process can be both life changing and saving.